⏳ Fetching live dividend data...
Home › Calculator › LGNDV Dividend Calculator 2026
Ligand Pharmaceuticals Incorporated · NASDAQ
Price: $50.00 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in LGNDV → $14.8K in 10 years · $47.44/month
Ligand Pharmaceuticals Incorporated is a biopharmaceutical entity dedicated to sourcing and developing innovative technologies that empower global pharmaceutical companies in their quest to discover and bring new medications to market. The company's diverse commercial portfolio features prominent treatments such as Kyprolis and Evomela, both prescribed for multiple myeloma; Veklury, addressing moderate or severe COVID-19; and a Teriparatide injection product for osteoporosis management. Their infectious disease arsenal includes Vaxneuvance, designed to prevent invasive illnesses caused by Streptococcus pneumoniae, and Pneumosil, a crucial pneumococcal conjugate vaccine combating pneumococcal pneumonia in pediatric populations. Furthermore, Ligand offers Rylaze, a recombinant erwinia asparaginase, indicated for treating acute lymphoblastic leukemia or lymphoblastic lymphoma in both adult and younger patients. The company leverages its proprietary Captisol technology in several key products: Nexterone, an amiodarone formulation; Zulresso, a brexanolone formulation for postpartum depression; and Noxafil-IV, an intravenous posaconazole formulation. Other notable products include Duavee for postmenopausal osteoporosis, the Aziyo portfolio encompassing commercial pericardial repair and CanGaroo envelope extracellular matrix products, Exemptia for autoimmune conditions, Vivitra for breast cancer, Bryxta and Zybev for a range of therapeutic areas, and Minnebro for hypertension. Beyond its direct product sales, Ligand also has a robust pipeline of partnered and licensed programs undergoing clinical development, targeting significant therapeutic areas such as various cancers, seizure disorders, diabetes, cardiovascular diseases, muscle wasting, liver and kidney ailments, and other medical conditions. Additionally, the company is a supplier of Captisol materials. Established in 1987, Ligand Pharmaceuticals is headquartered in San Diego, California.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open LGNDV position with:
Real after-tax yield depends on where you live and how you hold LGNDV.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 4.00% | 1.20% | $400 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 3.40% | 0.60% | $340 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 3.20% | 0.40% | $320 / yr |
| 🇬🇧 UK ISA | 0% | 4.00% | 1.20% | $400 / yr |
| 🇬🇧 UK Taxable | 8.75% | 3.65% | 0.85% | $365 / yr |
| 🇨🇦 TFSA | 0% | 4.00% | 1.20% | $400 / yr |
| 🇨🇦 CA Taxable | 25% | 3.00% | 0.20% | $300 / yr |
| 🇦🇺 Super (pension) | 15% | 3.40% | 0.60% | $340 / yr |
| 🇦🇺 AU Taxable | 30% | 2.80% | 0.00% | $280 / yr |
| 🇩🇪 DE Taxable | 26.375% | 2.95% | 0.15% | $295 / yr |
| 🇫🇷 FR Taxable | 30% | 2.80% | 0.00% | $280 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
LGNDV pays quarterly — 4 times per year. Next ex-div: TBD.
How LGNDV compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for LGNDV sourced from FMP /financial-growth endpoint — real data, not estimates.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the LGNDV dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Ligand Pharmaceuticals Incorporated (LGNDV) is currently trading at $50.00, trading near its 52-week low. The current dividend yield is 4.00% based on an annual payout of $2.00 per share.
Ligand Pharmaceuticals Incorporated (LGNDV) is a healthcare stock currently trading at $50.00 with a dividend yield of 4.00%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever